An scFv consists of the variable regions of an immunoglobulin's heavy chain (VH) and light chain (VL), connected by a flexible linker peptide, retaining the antigen-binding properties of IgG Antibodies. Compared to the traditional hybridoma technology for producing full-length IgG, scFvs offer advantages including small size, strong specificity, and suitability for large-scale production in E. coli expression systems. With a size of only about 25 kDa, scFvs exhibit enhanced diffusion within tumors and higher blood clearance rates. Several scFvs have been approved for clinical use in targeted tumor therapy.

KMD Bioscience possesses mature technologies for scFv Antibody Library Construction, Screening, Expression, and Purification, giving us clear advantages in Recombinant Antibody Preparation. We provide high-quality scFv preparation services utilizing various protein expression systems. Additionally, we develop customized Antibody Characterization and Functional Validation plans to ensure the rapid assessment of scFv antibody function and effectiveness.

We are committed to producing high-quality Antibodies to meet our clients' needs. Our prepared scFv Antibodies specifically bind to their target antigens and possess the correct binding epitopes, ensuring clear visibility in any background. During the production of high-quality Antibodies, we employ robust Antibody Functional Validation techniques to guarantee the quality and effectiveness of the antibodies delivered to clients, providing authentic validation data. Antibody quality primarily depends on two key characteristics: Affinity and Specificity. Affinity measures the strength of interaction between the epitope and the antibody's antigen-binding site; higher Affinity generally leads to greater detection sensitivity. Specificity refers to the antibody's ability to distinguish between different antigens, as some antibodies may produce false-positive results.

KMD validate all prepared scFv Antibodies using common immunological laboratory techniques, conducting Antibody Evaluation and Experimental Parameter Optimization to ensure result reliability. We verify antibody reproducibility, specificity, stability, and affinity through techniques including Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunofluorescence (IF), Enzyme-Linked Immunosorbent Assay (ELISA), Immunoprecipitation (IP), Chromatin Immunoprecipitation (ChIP), Peptide Arrays, Flow Cytometry (FC), Immunofluorescence Imaging (IF), and Gene-knockout Cell Lines. This ensures our prepared scFv Antibodies meet client requirements.